INKT: Buell Jennifer sold $73K of stock

By AlphaYouPublished Oct 14, 2026Form 4

Stocks in this disclosure

Reported activity

Buell Jennifer

Reporting filer

Buell Jennifer reported selling 6,938 shares of MiNK Therapeutics, Inc. for about $73K ($10.56 a share on average). Form 4 filed Oct 14, 2026 lists 3 entries.

See the price move since this trade →

Disclosed: Oct 14, 2026

Reported details

3 entries

All validated entries in this disclosure
Security	Owner	Date	Code	Action	Quantity	Price	Following holdings	Reporting delay	Filed terms and references
Common Stock	Buell Jennifer	2026-10-11	M	Exercise or conversion	23191	Not stated (see footnotes)	81,133	3 days	Filed terms security Title: Common Stock transaction Date: 2026-10-11 transaction Form Type: 4 transaction Code: M equity Swap Involved: false transaction Shares: 23191 id: F1 transaction Acquired Disposed Code: A shares Owned Following Transaction: 81133 direct Or Indirect Ownership: D
Common Stock	Buell Jennifer	2026-10-12	S	Sale	6938	10.56	74,195	2 days	Filed terms security Title: Common Stock transaction Date: 2026-10-12 transaction Form Type: 4 transaction Code: S equity Swap Involved: false transaction Shares: 6938 id: F2 transaction Price Per Share: 10.56 id: F3 transaction Acquired Disposed Code: D shares Owned Following Transaction: 74195 direct Or Indirect Ownership: D
Restricted Stock Units (derivative)	Buell Jennifer	2026-10-11	M	Exercise or conversion	23191	0.00	46,382	3 days	Filed terms security Title: Restricted Stock Units id: F1 transaction Date: 2026-10-11 transaction Form Type: 4 transaction Code: M equity Swap Involved: false transaction Shares: 23191 transaction Price Per Share: 0.00 transaction Acquired Disposed Code: D id: F4 id: F4 underlying Security Title: Common Stock underlying Security Shares: 23191 shares Owned Following Transaction: 46382 direct Or Indirect Ownership: D

Common Stock

Owner: Buell Jennifer
Date: 2026-10-11
Code: M
Action: Exercise or conversion
Quantity: 23191
Price: Not stated (see footnotes)
Following holdings: 81,133
Reporting delay: 3 days
Filed terms and references: Filed terms
security Title: Common Stock
transaction Date: 2026-10-11
transaction Form Type: 4
transaction Code: M
equity Swap Involved: false
transaction Shares: 23191
id: F1
transaction Acquired Disposed Code: A
shares Owned Following Transaction: 81133
direct Or Indirect Ownership: D

Common Stock

Owner: Buell Jennifer
Date: 2026-10-12
Code: S
Action: Sale
Quantity: 6938
Price: 10.56
Following holdings: 74,195
Reporting delay: 2 days
Filed terms and references: Filed terms
security Title: Common Stock
transaction Date: 2026-10-12
transaction Form Type: 4
transaction Code: S
equity Swap Involved: false
transaction Shares: 6938
id: F2
transaction Price Per Share: 10.56
id: F3
transaction Acquired Disposed Code: D
shares Owned Following Transaction: 74195
direct Or Indirect Ownership: D

Restricted Stock Units (derivative)

Owner: Buell Jennifer
Date: 2026-10-11
Code: M
Action: Exercise or conversion
Quantity: 23191
Price: 0.00
Following holdings: 46,382
Reporting delay: 3 days
Filed terms and references: Filed terms
security Title: Restricted Stock Units
id: F1
transaction Date: 2026-10-11
transaction Form Type: 4
transaction Code: M
equity Swap Involved: false
transaction Shares: 23191
transaction Price Per Share: 0.00
transaction Acquired Disposed Code: D
id: F4
id: F4
underlying Security Title: Common Stock
underlying Security Shares: 23191
shares Owned Following Transaction: 46382
direct Or Indirect Ownership: D

Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.

Filing context

Quantities and prices are shown in the units filed. No trade value is inferred from their product.
Buell Jennifer: Chief Executive Officer, Director.
F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of MiNK Therapeutics, Inc. (the "Company").
F2: Represents sales of shares, as a consequence of the vesting of restricted stock units, solely to satisfy tax withholding obligations incurred upon vesting.
F3: Represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $10.33 to $10.61. The reporting person undertakes to provide to the Company, any shareholder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4: On October 11, 2023 the reporting person was granted RSUs under the Company's 2021 Equity Incentive Plan, vesting in three substantially equal annual installments on each of the third, fourth and fifth anniversaries of the grant date. This award was previously reported as covering 695,750 RSUs but was adjusted to 69,573 RSUs to reflect the 1-for-10 reverse stock split (rounding) that occurred on January 28, 2025.

Original sources

SEC ownership filing

Prepared automatically from public filing data. Report a correction.

Security

Owner

Date

Code

Action

Quantity

Price

Following holdings

Reporting delay

Filed terms and references

Common Stock

Buell Jennifer

2026-10-11

Exercise or conversion

23191

Not stated (see footnotes)

81,133

3 days

Filed terms

security Title: Common Stock
transaction Date: 2026-10-11
transaction Form Type: 4
transaction Code: M
equity Swap Involved: false
transaction Shares: 23191
id: F1
transaction Acquired Disposed Code: A
shares Owned Following Transaction: 81133
direct Or Indirect Ownership: D

Common Stock

Buell Jennifer

2026-10-12

Sale

6938

10.56

74,195

2 days

Filed terms

security Title: Common Stock
transaction Date: 2026-10-12
transaction Form Type: 4
transaction Code: S
equity Swap Involved: false
transaction Shares: 6938
id: F2
transaction Price Per Share: 10.56
id: F3
transaction Acquired Disposed Code: D
shares Owned Following Transaction: 74195
direct Or Indirect Ownership: D

Restricted Stock Units (derivative)

Buell Jennifer

2026-10-11

Exercise or conversion

23191

0.00

46,382

3 days

Filed terms

security Title: Restricted Stock Units
id: F1
transaction Date: 2026-10-11
transaction Form Type: 4
transaction Code: M
equity Swap Involved: false
transaction Shares: 23191
transaction Price Per Share: 0.00
transaction Acquired Disposed Code: D
id: F4
id: F4
underlying Security Title: Common Stock
underlying Security Shares: 23191
shares Owned Following Transaction: 46382
direct Or Indirect Ownership: D

Filing context

Quantities and prices are shown in the units filed. No trade value is inferred from their product.

Buell Jennifer: Chief Executive Officer, Director.

F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of MiNK Therapeutics, Inc. (the "Company").

F2: Represents sales of shares, as a consequence of the vesting of restricted stock units, solely to satisfy tax withholding obligations incurred upon vesting.

F3: Represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $10.33 to $10.61. The reporting person undertakes to provide to the Company, any shareholder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F4: On October 11, 2023 the reporting person was granted RSUs under the Company's 2021 Equity Incentive Plan, vesting in three substantially equal annual installments on each of the third, fourth and fifth anniversaries of the grant date. This award was previously reported as covering 695,750 RSUs but was adjusted to 69,573 RSUs to reflect the 1-for-10 reverse stock split (rounding) that occurred on January 28, 2025.